Accordingly, acute treatment with NO∙ donors results in a reduction of insulin-stimulated glucose uptake and glycogen synthesis in isolated soleus muscle, inducing decreased IRβ and IRS-1 activity. In vivo, this treatment also promotes insulin resistance in healthy animals by the reduction of IRS-1 levels. This evidence concerns the gene IRS1 and Insulin resistance.